Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × cediranib × Clear all

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 Cyclophosphamide 8 apatinib 7 anlotinib 7 Vincristine 5 Dactinomycin 5 toripalimab 3 camrelizumab 3 Trabectedin 3 Etoposide 3 Docetaxel 3 brostallicin 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Radiation Dose Hypofractionation 2 Oncolytic Virotherapy 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Gene Expression Profiling 2 Gemcitabine 2 Drug Therapy 2 Busulfan 2 Amplified Fragment Length Polymorphism Analysis 2 trofosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01337401 2019-01-24

CASPS

Institute of Cancer Research, United Kingdom

Phase 2 Unknown

Sarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡